Skip to main content
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in the medicinal chemistry and rational drug design for the discovery of new Immunology, Endocrine & Metabolic Agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Immunology, Endocrine & Metabolic medicinal chemistry.

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Immunology, Endocrine & Metabolic drug discovery.

Publisher: Bentham Science Publishers

More about this publication?
Volume 8, Number 3, 2008

Articles

Favourites:
ADD

Targeted Therapies - Many Ways to (the Peace of) Rome
pp. 200-206(7)
Authors: Aringer, Martin; Smolen, Josef S.

Favourites:
ADD
Favourites:
ADD

Anti-CD20 in Targeting B Lymphocytes for the Treatment of Autoimmune Diseases: Clinical Benefits and Insights into the Role of B Lymphocytes in Pathophysiology
pp. 222-234(13)
Authors: Youinou, Pierre; Taher, Taher E.; Mankai, Amani; Berthou, Christian; Mageed, Rizgar

Favourites:
ADD

Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression
pp. 235-246(12)
Authors: Jones, Simon A.; Jones, Gareth W.; Williams, Anwen S.; Nowell, Mari A.

Favourites:
ADD

IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis
pp. 247-251(5)
Authors: Toh, Myew-Ling; Miossec, Pierre

Favourites:
ADD

Overview of the Role of Annexin 1 in the Innate and Adaptive Immune Response
pp. 252-258(7)
Authors: D'Acquisto, Fulvio; Perretti, Mauro

Favourites:
ADD

“Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?
pp. 259-274(16)
Authors: Toms, Tracey E.; Panoulas, Vasileios F.; Stavropoulos-Kalinoglou, Antonios; Kitas, George D.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content